BRPI9914996A - Anabolic implant composition and process to stimulate increased growth rate, greater amount of growth and greater feed efficiency in an animal. - Google Patents

Anabolic implant composition and process to stimulate increased growth rate, greater amount of growth and greater feed efficiency in an animal.

Info

Publication number
BRPI9914996A
BRPI9914996A BRPI9914996A BRPI9914996A BRPI9914996A BR PI9914996 A BRPI9914996 A BR PI9914996A BR PI9914996 A BRPI9914996 A BR PI9914996A BR PI9914996 A BRPI9914996 A BR PI9914996A BR PI9914996 A BRPI9914996 A BR PI9914996A
Authority
BR
Brazil
Prior art keywords
animal
growth
feed efficiency
implant composition
growth rate
Prior art date
Application number
BRPI9914996A
Other languages
Portuguese (pt)
Inventor
Chung Shih
Thomas J Kennedy
Peter James Knight
Daniel S Robins
Zezhi Jesse Shao
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BRPI9914996A publication Critical patent/BRPI9914996A/en
Publication of BRPI9914996B1 publication Critical patent/BRPI9914996B1/en
Publication of BRPI9914996B8 publication Critical patent/BRPI9914996B8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

patente de invenção:<b>''composições estimulantes de crescimento melhorado''<d>. um estimulante de peso e crescimento melhorado para animais domésticos tais como gado, porcos e ovelhas compreendendo um agente anabólico que é subcutaneamente administrado na forma de uma formulação de implante de liberação dual. ganhos aumentados são particularmente melhorados, quando zeranol é administrado em uma formulação de liberação imediata e de liberação controlada que permite uma injeção de dosagem a um só tempo.patent:<b>''enhanced growth stimulant compositions''<d>. an improved weight and growth stimulant for domestic animals such as cattle, pigs and sheep comprising an anabolic agent that is subcutaneously administered in the form of a dual release implant formulation. Enhanced gains are particularly improved when zeranol is administered in an immediate-release and controlled-release formulation that allows for a one-time dosing injection.

BRPI9914996-6 1998-11-04 1999-11-02 Anabolic implant composition and process to stimulate increased growth rate, greater amount of growth and greater feed efficiency in an animal. BRPI9914996B8 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04
PCT/US1999/023993 WO2000025743A2 (en) 1998-11-04 1999-11-02 Improved growth stimulant compositions

Publications (3)

Publication Number Publication Date
BRPI9914996A true BRPI9914996A (en) 2001-07-10
BRPI9914996B1 BRPI9914996B1 (en) 2011-11-01
BRPI9914996B8 BRPI9914996B8 (en) 2021-07-06

Family

ID=22683037

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9914996-6A BR9914996A (en) 1998-11-04 1999-11-02 Stimulating compositions for improved growth
BRPI9914996-6 BRPI9914996B8 (en) 1998-11-04 1999-11-02 Anabolic implant composition and process to stimulate increased growth rate, greater amount of growth and greater feed efficiency in an animal.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR9914996-6A BR9914996A (en) 1998-11-04 1999-11-02 Stimulating compositions for improved growth

Country Status (11)

Country Link
AR (1) AR025133A1 (en)
AU (1) AU777393B2 (en)
BR (2) BR9914996A (en)
CA (1) CA2348841C (en)
CO (1) CO5140100A1 (en)
CR (1) CR6351A (en)
MY (1) MY134868A (en)
PE (1) PE20001092A1 (en)
TW (1) TWI250027B (en)
WO (1) WO2000025743A2 (en)
ZA (1) ZA200103494B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
EP4000688A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution
EP4001288A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit
EP4001289B1 (en) 2020-11-19 2023-05-03 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of trenbolone and/or trenbolone acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573307B1 (en) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog EXTENDED RELEASE ANABOLIZING IMPLANTS
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Also Published As

Publication number Publication date
CA2348841A1 (en) 2000-05-11
BRPI9914996B8 (en) 2021-07-06
AR025133A1 (en) 2002-11-13
BR9914996A (en) 2001-07-10
WO2000025743A3 (en) 2000-08-24
AU777393B2 (en) 2004-10-14
CA2348841C (en) 2007-04-17
WO2000025743A2 (en) 2000-05-11
PE20001092A1 (en) 2000-10-31
ZA200103494B (en) 2002-07-30
BRPI9914996B1 (en) 2011-11-01
TWI250027B (en) 2006-03-01
CO5140100A1 (en) 2002-03-22
MY134868A (en) 2007-12-31
AU3096700A (en) 2000-05-22
CR6351A (en) 2003-11-20

Similar Documents

Publication Publication Date Title
AR045142A1 (en) BUEN SABOR DUCTILE MASTICABLE VETERINARY COMPOSITION
BR0008590A (en) Polymeric delivery agent, composition, unit dosage form, method for administering a biologically active agent to an animal requiring the agent, method for preparing a composition; it&#39;s composed
BR9906903A (en) Composition with sustained release, processes to produce it, to suppress the sudden initial release of the bioactive substance of a composition with sustained release and to increase the efficiency of including the bioactive substance in a composition with sustained release, pharmaceutical product, agent to prevent or treat prostate cancer, prostatic hypertrophy, endometriosis, hysteromyoma, metrofibroma, precocious puberty, dysmenorrhea, or breast cancer, or a contraceptive, and, compound
BR0306982A (en) Compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, methods to reduce the calcium conductance of a cell capsaicin receptor, to inhibit the binding of vanilloid ligand to a capsaicin receptor in vitro and in a patient, to treat a condition responsive to modulation of the capsaicin receptor in a patient, to treat pain in a patient, to treat itching in a patient, to treat coughing or hiccups in a patient, to promote weight loss in an obese patient, and to determine the presence or absence capsaicin receptor in a sample, packaged pharmaceutical preparation, and use of a compound
RS54187B1 (en) Controlled release pharmaceutical compositions comprising a fumaric acid ester
BRPI0412211A (en) controlled release compositions
BR0316305A (en) A compound or a pharmaceutically acceptable salt thereof, methods for treating pain in an animal, for stimulating opioid receptor function in a cell, for preparing a composition, and for treating diarrhea in an animal, composition, and kit.
AR098251A2 (en) USE OF AIVLOSIN OR AN ACID ADDITION SALT OF THE SAME PHARMACOLOGICALLY ACCEPTED FOR THE PREPARATION OF A VETERINARY USE MEDICINAL PRODUCT, A FOOD FOR CORRAL BIRDS OR PIGS, A STABLE COVERED COMPOSITION TO BE ADDED TO THIS FOOD
BRPI0512274A (en) aryl-substituted piperazine derivatives
BR0317168A (en) A compound or a pharmaceutically acceptable form thereof, pharmaceutical composition, methods of reducing calcium conductance of a cellular capsaicin receptor, and inhibiting vanilloid ligand binding to a capsaicin receptor, methods of treating a condition responsive to capsaicin receptor modulation. , pain, itching, coughing or hiccups, urinary incontinence, promoting weight loss in a patient, and determining the presence or absence of capsaicin receptor in a sample, packaged pharmaceutical preparation, and use of a compound
BR0015974A (en) Use of levetiracetam, pharmaceutical composition, use of a pharmaceutical composition and methods to treat a patient administered with an amount of at least one compound and a disease and to selectively potentiate the therapeutic effect of a compound
BRPI0608924A8 (en) FOOD COMPOSITION AND METHOD FOR REARING AN ANIMAL.
BRPI0517719A (en) transmucosal veterinary composition comprising detomidine
BR0013116A (en) Oral treatment of pets with ectoparasiticide spinosyns
BR0214610A (en) Controlled release polymeric compositions of bone growth promoting compounds
BR9808417A (en) Pet food product
BR0010355A (en) Use of creatine as a feed additive
PL352061A1 (en) Composition containing carvacrol and thymol for the use as a bacteriside
BRPI0412332A (en) method for raising blood antioxidant levels in a feline, and, dietary composition suitable for feeding young pet animals
BR0102134A (en) Feed composition for a livestock, feed, and method for increasing body weight gain efficiency and livestock feed efficiency
BRPI9914996A (en) Anabolic implant composition and process to stimulate increased growth rate, greater amount of growth and greater feed efficiency in an animal.
BR9106676A (en) PEPTIDE, PROCESS TO PROMOTE THE RELEASE OF GROWTH HORMONE LEVELS IN ANIMAL, PHARMACEUTICAL COMPOSITION TO PROMOTE THE RELEASE OF GROWTH HORMONE LEVELS IN ANIMALS, USE OF THE COMPOUND AND PROCESS TO PROMOTE THE LIBERATION IN THE ELEVATION BLOOD
RU2008139116A (en) METHODS FOR IDENTIFICATION OF FAT AND SKIN ANIMALS BY USING CLASS PREDICTORS
AR040488A1 (en) PREPARATIONS CONTAINING AT LEAST ONE DIFFEREMATE
HRP20041022B1 (en) Injectable veterinary composition for small animals